Malignant Abdominal Neoplasm: Clinical Trials

2 trials for Malignant Abdominal Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 recruiting. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Active not recruiting 1, Recruiting 1

Follow Malignant Abdominal Neoplasm: new trials by email Literature Review of Malignant Abdominal Neoplasm trials Research Report on Malignant Abdominal Neoplasm

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax
Atezolizumab, Cabozantinib S-malate, Nab-paclitaxel - Advanced Breast Carcinoma, Advanced Endometrial Carcinoma
Phase 1RecruitingM.D. Anderson Cancer Center432022-04-292026-07-16
Eribulin and Radiation Therapy in Treating Patients With Retroperitoneal Liposarcoma That Can Be Removed by Surgery
Eribulin Mesylate, Intensity-Modulated Radiation Therapy, Laboratory Biomarker Analysis - Liposarcoma, Malignant Abdominal Neoplasm
Phase 1Active not recruitingOHSU Knight Cancer Institute152018-03-192026-04-08

Narrower conditions

Breast Neoplasms (1)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Renal Cell (1)  ·  Endometrial Neoplasms (1)  ·  Fallopian Tube Neoplasms (1)  ·  Liposarcoma (1)  ·  Ovarian Neoplasms (1)

Broader conditions

Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Adenocarcinoma (1)  ·  Adnexal Diseases (1)  ·  Breast Diseases (1)  ·  Carcinoma (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Fallopian Tube Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Female (1)

Interventions

130-nm albumin-bound paclitaxel (1)  ·  Albumin-Bound Paclitaxel (1)  ·  Radiotherapy, Intensity-Modulated (1)  ·  Taxes (1)  ·  atezolizumab (1)  ·  cabozantinib (1)  ·  eribulin (1)

Sponsors

M.D. Anderson Cancer Center (1)  ·  OHSU Knight Cancer Institute (1)

Countries

United States (2)

Top investigators

Apostolia M Tsimberidou (1)  ·  Lara E Davis (1)

Results publications

PMID 32827353, PMID 42501677